Skip to main content
U.S. flag

An official website of the United States government

FTD Clinical Research: International trial network (Milestone 4.P)


Timeline Start - End

2020 - 2025

Research Implementation Area

Translational Tools, Infrastructure, and Capabilities

AD-Related Dementias Focus

Create an international FTD clinical trial network.

Success Criteria

  • Develop a patient registry for FTD clinical studies and a centralized database for de-identified clinical, genetic and biomarker information.

Summary of Key Accomplishments

In 2019, NIA and the NINDS co-funded the ALLFTD Study, a comprehensive clinical research network that is establishing the natural course of the various forms of FTD and will establish a baseline for clinical trials. In partnership with patient advocacy groups, a patient registry was launched (FTD Disorders Registry) and is fully integrated into the ALLFTD Study. The ALLFTD study also has collaborations with several industry partners developing potential therapies now poised for clinical trials. To increase the inclusion of underrepresented groups, the ALLFTD study has added sites in areas with enriched populations of race and ethnic minorities, is translating study materials into several languages, and conducted focused outreach efforts. ALLFTD is a formal partner with the international FTD Prevention Initiative (FPI).

The key accomplishments summary is current as of July 2022.

Accomplishments/Implementation Activities

Funding Initiatives

Research Programs and Resources

Relevant Recommendations

Related Milestones

Search all Research Categories

An official website of the National Institutes of Health